[1] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[2] |
HUANG Liting, TANG Zaixiang, BAI Lu, SHI Guanhong, JIANG Yiguo.
Adverse reactions of benzodiazepines based on FAERS database
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1223-1227.
|
[3] |
WANG Dan, WU Chen, REN Jingtian.
Risk analysis of dextromethorphan abuse
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1097-1099.
|
[4] |
HUANG Yuan, WANG Chenggang, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun.
Drug Abuse Monitoring Models in Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 607-612.
|
[5] |
WANG Jiayu, YU Dandan, LI Ming, WANG Ling, LIU Pengcheng, SUN Jun.
Current Abuse/Use of Compound Tramadol in Drug Abusers
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(2): 98-105.
|
[6] |
BAN bingkun, REN pengyu, WEI jingtu, CAO zijing.
Course of Development and Status quo of Drug Abuse Monitoring in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 777-779.
|
[7] |
WU Jianru, XIAO Xiao, LIU Xiaoyu, WANG Shu.
Epidemic Characteristics of First-time Drug Abuse and Influencing Factors of Synthetic Drug Abuse among Adolescents in Shenzhen
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 823-827.
|
[8] |
LIU Bin, LV Jialin, YIN Ruoyun, ZHOU Juan, HUANG Helang, WU Lei.
Risk of Narcotics and Psychotropic Substances Abuse among Drug Abusers
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 828-832.
|
[9] |
WANG Chenggang, HUANG Yuan, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun.
Survey about Medical Staff's Knowledge of Drug Abuse Monitoring in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 697-702.
|
[10] |
SUN Jun, YU Dandan, LI Ming, WU Chen, LIU Pengcheng, WANG Jiayu.
Analysis of Current Abuse among Drug Abusers in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(1): 37-44.
|
[11] |
GUO Fei, LI Tao, SUN Ruijie, NIU Huifang, HUANG Yunhui, CHEN Yongxin, WANG Jinbao, ZHANG Ruiling.
Effects of Clinical Pharmacists Intervention on the Use of Psychotropic Drugs of Category Ⅱin a Psychiatric Hospital
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 550-554.
|
[12] |
YU Dandan, SUN Jun, WANG Jiayu, WU Chen, LIU Pengcheng.
Analysis of Factors Influencing Abuse/Use Behavior of Compound Tramadol
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 543-549.
|
[13] |
SUN Zhenhui, WANG Jiayu, YU Dandan, WANG Ling, YU Zheng.
Survey on Gender Differences among Abusers/Users of Compound Tramadol
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 536-542.
|
[14] |
SUN Zhenhui, SUN Jun, WANG Jiayu, YU Dandan, WANG Ling, YU Zheng.
Research on the Status Quo of the Regulation of Compound Tramadol
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 528-535.
|
[15] |
WAN Kaihua, WEI Yu, XU Yuming, ZHOU Juan.
Current Status of Drug Abuse Epidemic and Intervention Research in China
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 338-341.
|